[Form 4] RH Insider Trading Activity

Rhea-AI Filing Summary

On 06/26/2025, RH (ticker: RH) filed a Form 4 reporting that director Kathleen C. Mitic received an award of 670 shares of RH common stock at a cost basis of $0.00. The filing states that the restricted stock will vest in full one year from the grant date. After the grant, Mitic’s direct beneficial ownership rises to 12,056 shares. No sales, derivative securities, or Rule 10b5-1 plan transactions were disclosed.

Insights

Financial Analyst

TL;DR: Routine director stock grant; immaterial to RH valuation.

The 670-share award equals roughly 0.03% of RH’s ~32 million shares outstanding and is standard board compensation. While it marginally aligns director and shareholder interests, the event does not alter cash flow, guidance, or capital structure. I therefore view the disclosure as neutral for investors.

Corporate Governance Expert

TL;DR: Standard equity incentive, reinforces alignment without signaling.

Restricted stock grants are customary for independent directors and do not imply management sentiment beyond routine governance practice. The one-year vesting horizon is typical and poses no dilution concern. Overall governance impact is neutral; no red flags or positive inflections identified.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mitic Kathleen C.

(Last) (First) (Middle)

C/O RH

15 KOCH ROAD, SUITE K

(Street)

CORTE MADERA CA 94925

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RH [ RH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/26/2025		A		670(1)	A	$0	12,056	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This award of restricted stock will vest in full on the one-year anniversary of the date of grant.

	/s/ Jill Falor, Attorney-in-Fact	06/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did RH report on 06/26/2025?

Director Kathleen C. Mitic was granted 670 shares of RH restricted stock at $0.00, according to the Form 4.

How many RH shares does Kathleen C. Mitic now own?

Following the grant, Mitic’s direct beneficial ownership is 12,056 common shares.

When will the 670 restricted shares awarded to Mitic vest?

The restricted stock is scheduled to vest in full on the one-year anniversary of the 06/26/2025 grant date.

Were any derivative securities involved in the RH Form 4 filing?

No. The filing shows no derivative securities acquired or disposed of by the reporting person.

Does the filing reference a Rule 10b5-1 trading plan?

The box for a Rule 10b5-1 plan was not checked; the filing does not indicate the transaction was under such a plan.